Putting Patients First—KCR’s Contribution to Patient-Centric Approach in Clinical Trials
Berlin-September 18, 2017-Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber. The project has been designed to learn more about patients in clinical trials; it is based on the voices and perspectives of real patients who are participating in clinical trials.
“Clinical trials focus around patients’ needs and improve the quality of their life. However, we as the R&D industry do not know much about the real patients’ experience before and during the clinical trial enrollment: what are their thoughts, what are their fears? The idea behind the project was to receive feedback from patients who have been or are part of a clinical trial regarding their motivations, concerns, and convictions, said Mike Jagielski, President & CEO of KCR.
The CRO teamed up with a service design firm, The Story, to conduct the project as a service design study. The project team built direct and meaningful contacts with patients gathering their views via interviews and workshops. It has resulted in recognizing the journey of patients in a clinical trial and mapping their emotions at every stage.
“The industry talks a lot about a patient-centric approach nowadays but finding real comments from patients is not so easy. #HumanBehindEveryNumber brings you close to patients to learn how they feel when they are treated with a new drug, which questions they have and which answers they need and receive,” added Mr. Jagielski.
The project has been conducted across different countries, so far including Ukraine, Bulgaria, Poland, Germany, and UK, with the US in the nearest plans. The study is ongoing and the team is continuously gathering biographies of people struggling with different diseases and documenting their lives as patients in clinical trials. All these makes the unique content of the project website: humanbehindeverynumber.com including the real patients’ voices and maps of their emotions.
“We wish to share the project results with the whole industry, initiate a discussion about measurement scales, and develop effective methodologies with specialists from pharma, CROs, and service design companies. We believe that a truly patient-centric approach will contribute to a better trial design in the future. However, to reach this point we need to research thoroughly what patient centricity means exactly,” summarized Mr. Jagielski.
Should you need any further information about #HumanBehindEveryNumber and/or would like to speak to KCR’s CEO, Mike Jagielski, please contact Joanna Lewandowska, PR & Marketing, at joanna.lewandowska@kcrcro.com.
The media pack of the project is available under this link.
If you would like to join the project as a patient and share your story, or became a partner to shape the future of clinical trial design together with KCR, please click here or contact us at info@humanbehindeverynumber.com
About KCR
KCR is a Contract Research Organization (CRO) providing clinical development solutions for the pharmaceutical, biotechnology and medical device industries. More than 300 professionals support clients with full-service capabilities across our three main service areas: Trial Execution (TE), Functional Service Provision (FS) and Late Phase (LP). Focusing on knowledge, quality and innovation, KCR offers reliable, customized and fast solutions to fulfill the clients' needs. The company’s geographical set up suits perfectly to deliver optimized trial execution strategies. Headquartered in Berlin, Germany, KCR operates across 20 countries in Europe, Asia as well as the U.S. This year the company celebrates its 20th anniversary. For more information, visit www.kcrcro.com
KCR: We see human behind every number.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
